2018 Spain Automated Microbiology Market: Supplier Shares and Segmentation Forecasts--Molecular Dx, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities

Date: October 8, 2018
Pages: 417
Price:
US$ 4,750.00
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 2BCC68F3DF4EN
Leaflet:

Download PDF Leaflet

2018 Spain Automated Microbiology Market: Supplier Shares and Segmentation Forecasts--Molecular Dx, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities
Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500.

VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the Spain automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding Spain microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis
  • Sales and market shares for major suppliers by individual test.
  • Volume and sales forecasts for over 100 infectious disease assays by individual test:
  • Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
  • Review of the market dynamics, trends, structure, size, growth and major suppliers.
Specimen Types
  • Urine
  • Sterile Fluids: Blood, Serum, CSF
  • Throat Swabs, Respiratory Secretions
  • Genital Secretions
  • Stool
  • Abscess/Wound
  • Sputum
  • Saliva
Applications
  • Microbial Identification
  • Antibiotic Susceptibility
  • Urine Screening
  • Blood Cultures
Review of Major Automated Systems
  • Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
  • The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.
Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review
  • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
  • Global listings of companies developing or marketing microbiology products by individual test.
Competitive Assessments
  • Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
  • The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Biotest, CellMark Forensics/LabCorp, Cepheid, Decode Genetics, Diadexus, Diamedix/Erba, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Illumina, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.
Opportunities and Strategic Recommendations
  • Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
  • Design criteria for decentralized testing products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Contains 417 pages and 75 tables
I. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
  1. Major Factors Affecting Market Penetration of Microbiology Instrumentation
  2. Traditional Practices
  3. Technological Challenges
  4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
  1. Urine
  2. Sterile Fluids: Blood, Serum, and CSF
  3. Throat Swabs and Respiratory Secretions
  4. Genital Secretions
  5. Stool
  6. Abscess/Wound
  7. Sputum
  8. Saliva
C. Test Applications
  1. Microbial Identification
  2. Antibiotic Susceptibility
  3. Urine Screening
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
  1. Multiple Purpose Microbiology Systems
  2. Specialized Microbiology Systems
  3. Molecular Diagnostic Systems
  4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
    a. DNA Sequencing
       Introduction
       Sequencing Methods
       Autoradiography
       The Human Genome Project
       Sequencing Automation
       Image Scanners
       Fluorescent Detection
       Gene Profiling
       Gene Expression
       Polymorphism Screening
       Protein Interaction Networks
    b. DNA And RNA Probe Technology
       Basic Principles
       Probe Preparation
       The DNA Probe Test
       Sample Preparation
       Hybridization
        Separation
        Detection/Measurement
       Test Formats
       Filter Hybridization
       Southern Blot
       Northern Blot
       In Situ Hybridization
       Others
       Labeling Techniques
       Amplification Methods
       Polymerase Chain Reaction
       Temperature Cyclers
       PCR Variations
       Immuno-PCR
       QC-PCR
       DAP-PCR
       Strand Displacement Activation
       TMA
       Ligase Chain Reaction
       Branched DNA
       Hybridization Protection Assay
       Nucleic-Acid Sequence-Based Amplification
       Self-Sustained Sequence Replicase
       Others
       Ampliprobe
       CAR
       CAS
       CPT
       Dendritic Polymer Technology
       ISO-CR
       LAT
       Probe
       RAMP
       Repair Chain Reaction
       Rolling Circles
       Sequence Independent Gene Amplification
       Sequence Initiation Reaction
       SISPA
       Solid Phase Amplification
    c. Detection Technologies
       Radioactive Methods
       Overview
       Major Isotopes
       P-32
       S-35
       H-3
       I-125
       Non-Isotopic Methods
       Enzymatic Labels
       Chemical Labeling
       Indirect Chemical Labeling
       Direct Chemical Labeling
       Fluorescence
       Chemiluminescence
       Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
     Liquid Transportation and Mixing
        Separation
        Reaction
        Detection
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

II. SPAIN

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/Lab Corp
Decode Genetics
Diadexus
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech/Leica
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher
Wallac/PE
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Spain Laboratories Performing Microbiology Tests by Market Segment
Spain Hospital Laboratories Performing Microbiology Tests by Bed Size
Spain Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
Spain All Market Segments Microbiology Specimen Volume
Spain Hospital Laboratories Microbiology Specimen Volume
Spain Commercial/Private Laboratories Microbiology Specimen Volume
Spain Microbiology Test Volume by Market Segment
Spain Microbiology Test Volume by Application
Spain Microbial Identification Test Volume by Market Segment
Spain Urine Screening Test Volume by Market Segment
Spain Blood Culture Test Volume by Market Segment
Spain Antibiotic Susceptibility Test Volume by Market Segment
Spain Microbiology Consumables Market by Application
Spain Microbiology Consumables Market by Market Segment
Spain Microbial Identification Consumables Sales by Market Segment
Spain Blood Culture Consumables Sales by Market Segment
Spain Antibiotic Susceptibility Consumables Sales by Market Segment
Spain Urine Screening Consumables Sales by Market Segment
Spain All Market Segments Infectious Disease Test Volume Forecast by Assay
Spain All Market Segments Infectious Disease Diagnostics Market Forecast by Test
Spain Infectious Disease Blood Screening NAT Volume Forecast by Assay
Spain Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Spain HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
Spain Chlamydia Testing Market Diagnostics Sales by Major Supplier
Spain CMV Testing Market Diagnostics Sales by Major Supplier
Spain Hepatitis Testing Market Diagnostics Sales by Major Supplier
Spain Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Spain Herpes Testing Market Diagnostics Sales by Major Supplier
Spain Influenza Testing Market Diagnostics Sales by Major Supplier
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Spain Meningitis Testing Market Diagnostics Sales by Major Supplier
Spain Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain RSV Testing Market Diagnostics Sales by Major Supplier
Spain Rotavirus Testing Market Diagnostics Sales by Major Supplier
Spain Rubella Testing Market Diagnostics Sales by Major Supplier
Spain Septicemia Testing Market Diagnostics Sales by Major Supplier
Spain Streptococci Testing Market Diagnostics Sales by Major Supplier
Spain Syphilis Testing Market Diagnostics Sales by Major Supplier
Spain Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Spain Trichomonas Testing Market Diagnostics Sales by Major Supplier
Spain Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Spain Molecular Diagnostics Market Sales and Shares of Major Suppliers
Skip to top


Ask Your Question

2018 Spain Automated Microbiology Market: Supplier Shares and Segmentation Forecasts--Molecular Dx, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: